According to a recent study, women who use the Ortho Evra birth-control patch are at double risk of developing blood clots than those taking oral contraceptives, the Food and Drug Administration said Friday.
However, the agency said that presented results are preliminary and hence they do not require prompt action other than advising women to discuss the risk with their physician.
The results of the research, along with another that reealed no greater risk, were made public on Thursday by the patch’s producer.
"The results are preliminary and further evaluation is necessary to understand what these results mean," said Dr. Daniel Shames, director of the division of reproductive and urological drugView the rest of this article
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment